Cliff Rowe
Impact in
- Pharmacology top 0.5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Hepatology top 2%
- Liver physiology and pathology
Papers in
-
- Drug-Induced Hepatotoxicity and Protection 8
-
- Liver physiology and pathology 4
- Co-authors
- Christopher E. Goldring (10 shared papers)Neil R. Kitteringham (6 shared papers)Neil A. Hanley (4 shared papers)Tomasz M. Kostrzewski (2 shared papers)Karen Piper Hanley (3 shared papers)Emma M. Large (2 shared papers)David J. Hughes (2 shared papers)Roz Jenkins (3 shared papers)
- Journals
- Archives of Toxicology (2 papers)Hepatology (2 papers)Journal of Proteome Research (2 papers)Blood (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Cliff Rowe
24 papers receiving 2.5k citations
Cliff Rowe's Hit Papers
Peers
Comparison fields: 5 of 92
- Pharmacology 715
- Hepatology 403
- Biomedical Engineering 613
- Small Animals 115
- Genetics 76
Countries citing papers authored by Cliff Rowe
This map shows the geographic impact of Cliff Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cliff Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cliff Rowe more than expected).
Fields of papers citing papers by Cliff Rowe
This network shows the impact of papers produced by Cliff Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cliff Rowe. The network helps show where Cliff Rowe may publish in the future.
Co-authors
The 25 scholars most cited alongside Cliff Rowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME Hit paper breakdown → | 2013 | 1055 |
| 2 | 2014 | 289 | |
| 3 | Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study Hit paper breakdown → | 2018 | 269 |
| 4 | 2017 | 125 | |
| 5 | 2013 | 112 | |
| 6 | 2015 | 109 | |
| 7 | 2016 | 109 | |
| 8 | 2012 | 81 | |
| 9 | 2016 | 55 | |
| 10 | 2010 | 54 | |
| 11 | 2015 | 46 | |
| 12 | 2010 | 43 | |
| 13 | 2009 | 37 | |
| 14 | 2015 | 32 | |
| 15 | 2017 | 32 | |
| 16 | 2007 | 26 | |
| 17 | 2013 | 23 | |
| 18 | 2012 | 20 | |
| 19 | 2017 | 19 | |
| 20 | 2018 | 14 |
About Cliff Rowe
Cliff Rowe is a scholar working on Pharmacology, Hepatology, Spectroscopy, Biomedical Engineering and Molecular Biology, having authored 24 papers that have together received 2.6k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (8 papers), Ultrasound and Hyperthermia Applications (5 papers), Pluripotent Stem Cells Research (4 papers), Liver physiology and pathology (4 papers), Advanced Proteomics Techniques and Applications (3 papers), Cancer therapeutics and mechanisms (1 paper), Pharmaceutical Economics and Policy (1 paper) and Liver Disease Diagnosis and Treatment (1 paper). The work is most often cited by research in Pharmacology (715 citations), Hepatology (403 citations), Biomedical Engineering (613 citations), Small Animals (115 citations) and Genetics (76 citations). Cliff Rowe has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Christopher E. Goldring, Neil R. Kitteringham, Neil A. Hanley, Tomasz M. Kostrzewski, Karen Piper Hanley, Emma M. Large, David J. Hughes, Roz Jenkins, B. Kevin Park and Andrew A. Berry. Their work appears in journals such as Archives of Toxicology, Hepatology, Journal of Proteome Research, Blood and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.